Quest Diagnostics CEO Sells 10,000 Shares for $2.4 Million

J. E. Davis disposed of 8% of his direct equity stake under a pre-planned Rule 10b5-1 trading arrangement, retaining $28.9 million in company stock.

CryptoAlerta — análise de criptomoedas e mercado em tempo real